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Our view of endocytosis and membrane trafficking of transmembrane receptors has
dramatically changed over the last 20 years. Several new endocytic routes have been
discovered and mechanistically characterized in mammalian cells. Long considered as
a passive means to terminate signaling through down-regulation of the number of acti-
vated receptors at the plasma membrane, it is now established that receptor endocytosis
and endosomal sorting can be directly linked to the regulation of intracellular signaling
pathways. The functional links between membrane trafficking of interferon receptors and
JAK/STAT signaling have recently begun to be unraveled. These studies raise the exciting
possibility that a certain level of signal specificity can be achieved through endocytosis and
selective localization of the activated complexes within cellular membranes. The ongoing
development of high-resolution cell imaging techniques with better spatial and temporal
resolution gives new means of deciphering the inherent complexity of membrane traffick-
ing and signaling. This should help to better comprehend the molecular mechanisms by
which endocytosis and endosomal sorting of interferon receptors can orchestrate signaling
selectivity within the JAK/STAT pathway that can be activated by as many as 60 different
cytokines, growth factors, and hormones.
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ENDOCYTIC PROCESSES IN MAMMALIAN CELLS
Endocytosis is a highly dynamic and tightly regulated process by
which solutes and macromolecules enter the cell and are distrib-
uted within intracellular compartments. This process is hijacked
by several pathogens and its physiological importance well illus-
trated by the severity of diseases involving mutations in associated
genes (1). Our view of endocytosis, and more broadly of mem-
brane trafficking, has dramatically changed over the past 20 years.
The availability of more selective tools and higher resolution cell
imaging microscopy has led to the discovery and characteriza-
tion of novel regulators and to the development of new concepts.
Long seen as a passive means to control the number of signaling
receptors at the plasma membrane, it is now clear that endocyto-
sis and endosomal sorting can play a more direct control on the
signaling outputs of several transmembrane receptors involved in
fundamental cellular processes. The past decade has confirmed
that in addition to the main clathrin-dependent pathway, sev-
eral other endocytic pathways can operate at the cell surface of
mammalian cells. The role of these alternate endocytic routes is
just now beginning to emerge. We must now seek to identify the
cargos that are internalized through these various pathways, to
define the associated molecular machineries, and to understand
the specific cellular functions that they regulate. Future work will
have to integrate the molecular knowledge of endocytic sorting
to other fields of research and to switch from purely descrip-
tive to more functional understanding. In this respect, cytokine
receptors, especially interferon receptors, have suffered from a rel-
ative disinterest from cell biologists. In this review, we describe
the recent progress on endocytosis and endosomal sorting of
signaling receptors and how this knowledge can be used as a
paradigm to better understand the biological activity of interferons
(IFN).
THE CLASSICAL CLATHRIN AND DYNAMIN DEPENDENT
ENDOCYTOSIS
Historically, clathrin-dependent endocytosis has been and still
is by far the most widely studied, and thus the best under-
stood endocytic pathway in mammalian cells. In fact, the vast
majority of transmembrane receptors are endocytosed through
clathrin-coated pits (CCP) (2). Clathrin-dependent endocytosis
was initially described on the basis of electron microscopy studies
that identified the first coated invaginated structures in the 1960s
(3, 4). The minimal machinery that is theoretically required to
assemble a functional endocytic structure is the structural unit
clathrin, the AP-2 complex that recognizes specific motifs on the
tail of endocytosed receptors, and the GTPase dynamin, which
mechanically mediates the closure and the detachment of the
clathrin-coated vesicle from the plasma membrane (5, 6). Never-
theless, many accessory proteins have since been shown to interact
with these three historical actors so as to integrate endocytosis
with other cellular machineries including the actin cytoskeleton,
lipids, and signaling molecules (7–9). Two endocytic behaviors are
schematically described for the initial steps of receptor uptake by
clathrin-dependent endocytosis. Receptors undergoing constitu-
tive endocytosis are internalized whether or not they have bound
their ligand. This is typical of receptors that bring nutrients into
the cell and best exemplified by the LDL and transferrin recep-
tors. In contrast, receptors endocytosed through ligand-induced
endocytosis undergo internalization only after binding to their
cognate ligand. This is the case of most receptor tyrosine kinases
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(RTK) such as the EGF-R, and of G-protein coupled receptors
(GPCR) that undergo endocytosis upon binding to their agonist
(10, 11). It is likely that this distinct behavior relies on ligand-
induced conformational change of the receptor that facilitates the
interaction of otherwise hidden endocytic motifs with the AP-2
complex in the case of RTKs or β-arrestins complex in the case of
GPCRs. Several aspects of the IFN-α receptor complex (IFNAR)
endocytosis support this hypothesis. The resting IFNAR complex
is in a conformation such that the receptor-associated Tyk2 kinase
masks the classicalYxxφ tyrosine-based endocytic motif (YVFF) in
position 466 of the IFNAR1 subunit, thereby preventing its recog-
nition by the AP-2 complex. IFN-α binding results in IFNAR1
ubiquitination, which in turn stimulates IFNAR1 internalization
by exposing its endocytic motif for AP-2 binding (12). Although
the endocytosis of the IFN-γ receptor complex (IFNGR) can also
be stimulated through ubiquitination by the Kaposi’s sarcoma-
associated herpes virus (KHSV) ubiquitin ligases K4 and K5 (13),
IFNGR endogenous ubiquitination induced by IFN-γ has not
been reported. IFNGR1 and IFNGR2, the two subunits of the
IFNGR complex, possess putative AP-2 binding motifs. A leucine-
isoleucine (LI) doublet and a typical YVSL tyrosine-based motif
are present in position 270–271 and 287–290 of IFNGR1, respec-
tively. Likewise, an YRGL motif is present on position 273–276 and
a LI doublet is found on position 255–256 of IFNGR2 (14). The
deletion of these motifs impairs the internalization of IFN-γ and
the uptake of IFNGR2 and IFNGR1 subunits (15–18). The dele-
tion of the corresponding LI motif on IFNGR2 does not result in
a strong inhibition of its endocytosis, implying that the tyrosine-
based endocytic motifs are also required for efficient uptake (15).
Accordingly, it was shown in 2006 that RNAi-mediated silencing
of clathrin and dynamin led to the accumulation of IFNGR1 at
the plasma membrane and inhibition of IFN-γ endocytosis in
several cell types (19). Whether other endocytic pathways can
also contribute to the uptake of the IFNGR complex remains to
be established (see below). It was recently shown that efficient
IFNGR1 uptake does not depend on the LI motif but on a new
287-YVSLI-291 motif including the already identified YVSL motif
and the two adjacent LI amino acids (20).
CLATHRIN-INDEPENDENT ENDOCYTOSIS
It has been now confirmed that in addition to the canonical
clathrin-dependent endocytosis, several distinct endocytic path-
ways can simultaneously operate in mammalian cells (Figure 1)
(21–23). These alternate pathways, which have been defined under
the generic name of clathrin-independent endocytosis, have their
own characteristics, but they also share some common features
such as the association with lipid microdomains, the role of the
actin cytoskeleton in cargo recruitment and vesicular scission,
and their distinct regulation by the Rho family of small GTPases
(Table 1).
CAVEOLAR ENDOCYTOSIS
Caveolae were discovered 10 years prior to CCP in mammalian
cells (24, 25). Caveolae are specialized membrane invaginations
that are particularly abundant at the surface of endothelial cells,
muscle cells, and adipocytes, but absent in lymphoid cells and
neurons (26). Caveolin-1 (Cav1) is the major constituent of cave-
olae and its oligomerization is sufficient to assemble a complete,
functional caveola. The second isoform Cav2 is less characterized,
while Cav3 is only expressed in muscle cells. The down-expression
of Cav1 and Cav3, but not Cav2, is sufficient to prevent the
formation of caveolae at the plasma membrane. Cavins, a new
FIGURE 1 | Multiple endocytic pathways operate in mammalian cells.
Cargo proteins can enter the cell by clathrin and clathrin-independent
endocytic pathways. The GTPase dynamin is required for the detachment of
endocytic carriers from the plasma membrane in the clathrin, caveolae, and
IL2-R pathways. The IL2-R pathways is the only clathrin and caveolae
independent pathway that requires dynamin for cargo uptake. Among the
other clathrin- and dynamin-independent pathways, we can distinguish
between Arf6- or flotillin-dependent endocytosis, GPI-AP uptake via
crescent-like intermediates (CLIC/GEEC pathway) and toxin-induced
invaginations (Shiga toxin). The plasma membrane is highly plastic and a given
receptor may use several of these pathways for entry and signaling. After
uptake, cargo molecules are trafficked to the sorting endosome where they
are either targeted to the lysosome for degradation or recycled back to the
plasma membrane through recycling endosomes.
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Table 1 | Morphological and molecular characteristics of the different clathrin-independent endocytic pathways operating in mammalian cells.
Endocytosis
pathway
Morphology Protein partners Cargo proteins
Dynamin dependent Caveolae Vesicular Caveolin-1, -2, -3, cavin-1, -2, -3, -4, Src,
PKC, actin
Cholesterol, glycosphingolipids, AMF,
lactosylceramide, CTxB, SV40, albumin
IL2-R Vesicular RhoA, Rac1, PAK1, PAK2, cortactin,
N-WASP, actin
IL2-Rß, γc chain, Clostridium toxin, AMF
Dynamin independent CLIC-GEEC Tubular,
crescent-like
Cdc42, Arf1, GRAF1, actin GPI-anchored proteins, fluid-phase uptake
markers
Arf6 Vesicular Arf6, actin CD59, MHCI, carboxypeptidase E,
β-integrins, E-cadherin
Flotillins Vesicular Flotillin-1,-2, actin GPI-anchored proteins, cholera toxin B
subunit
Toxins Tubular Actin Shiga toxin B subunit, cholera toxin B
subunit, SV40, galectins
family of cytosolic proteins involved in the assembly of caveolae
at the plasma membrane have been recently identified. This fam-
ily includes cavin-1 or polymerase I and transcript release factor
(PTRF), cavin-2 or serum deprivation protein response (SDPR),
cavin-3 or sdr-related gene product that binds to C-kinase (SRBC),
and cavin-4 or muscle restricted coiled–coil protein (MURC) (27).
Cavins interact with caveolins in a lipid dependent manner and
are required to maintain their invaginated structure. The down-
regulation of cavins leads to the disassembly of caveolae and to the
release of free caveolins that are subsequently degraded (28). The
resembling shape of caveolae with CCP initially prompted inves-
tigators to analyze their potential ability to mediate endocytosis.
Indeed, caveolae are 60–80 nm diameter cup-shaped membrane
invaginations that bear a characteristic striated coat visible by elec-
tron microscopy (29). The GTPase dynamin, which mediates the
mechanical release of CCP from the plasma membrane, has also
been found in caveolae and is required for caveolae detachment
from the cell surface. Yet, little evidence exists in support of a
prominent role of caveolae in endocytic uptake in mammalian
cells. Initial studies investigating the dynamics of caveolins by
FRAP microscopy (fluorescence after photobleaching recovery)
have revealed that the turnover of caveolins is very slow at the
plasma membrane at steady state (30). Nonetheless, caveolar endo-
cytosis can be efficiently triggered by caveolin tyrosine phosphory-
lation and appears to be regulated by Src kinase, protein kinase C
α and actin (26). Although caveolae have the ability to recruit and
concentrate various signaling molecules and effectors, no caveolar
specific cargo has been identified thus far (31). Yet, several car-
gos can be found associated with caveolae and undergo caveolar
endocytosis in a non-exclusive manner. This is the case with the
autocrine motility factor (AMF) and lactosylceramide that will
reach the endoplasmic reticulum after caveolar endocytosis (32,
33). It has been proposed that caveolae deliver cargo to a particu-
lar endosomal compartment called the caveosome (34). However,
it has been recently shown that this compartment is a likely arti-
fact resulting from caveolin overexpression (35). Both IFNGR and
IFNAR subunits display the typical endocytic codes recognized
by the clathrin-dependent endocytosis machinery, some studies
however found these receptors in caveolar domains. Early electron
microscopy studies showed that IFN-γ and the IFNGR1 subunit
were localized both in caveolae and CCPs (36). Likewise, IFNAR
was found to biochemically cofractionate with caveolin in murine
cells, implying a possible association with caveolae (37). These
studies then suggest that IFN receptors can be endocytosed by
caveolae in addition to their uptake through CCPs. This hypoth-
esis needs however to be confirmed by ultrastructural means and
quantitative dynamic experiments under selective conditions of
caveolar endocytosis inhibition.
NON-CAVEOLAR NON-CLATHRIN ENDOCYTOSIS
It has long been assumed that the uptake of transmembrane
receptors could only occur through CCP endocytosis (38). In
the early 2000s the use of selective molecular inhibitors of
clathrin-dependent endocytosis enabled the identification of the
interleukin-2 receptor (IL2-R) as the first transmembrane recep-
tor to be efficiently endocytosed in cells deprived of clathrin and
caveolin (39). IL2 binding led to the association of the IL2-R
with detergent-resistant membranes (DRM), the fraction col-
lected after detergent solubilization of cellular membrane and
flotation on a density gradient, reflecting the sensitivity of this
clathrin-independent pathway to cholesterol and sphingolipids.
The IL2-R pathway requires dynamin GTPase activity, a feature
that so far distinguishes this pathway from the other clathrin-
independent endocytic pathways that are dynamin-independent
(see below). Another characteristic of the IL2-R pathway is the
selective regulation by the Rho family of small GTPases (Table 1).
Other molecular regulators have since been characterized includ-
ing the p21-activated kinases PAK1 and PAK2, which can remodel
the actin cytoskeleton through cortactin phosphorylation and the
Wiskott–Aldrich syndrome neuronal protein N-WASP (40). The
IL2-R pathway is likely to be used by other cytokine receptors
including IL4, IL7, IL9, and IL15 which share the β and γ chains
of the IL2-R. It was recently shown that some bacterial toxins
of the Clostridium family can hijack the IL2-R pathway for cell
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intoxication (41). The AMF is endocytosed by a pathway that is
regulated in a similar manner except for the sensitivity to RhoA
(42). It is not known whether IFNAR and IFNGR can take the
IL2-R endocytic route.
DYNAMIN-INDEPENDENT ENDOCYTIC PATHWAYS
The seminal finding in 1995 that inhibiting the dynamin GTPase
does not block the overall endocytic activity of the cell raised
the possibility of dynamin-independent endocytic pathways (43).
Indeed, several clathrin- and dynamin-independent pathways have
since been identified and characterized (Figure 1). These pathways
have long been defined in negative terms due to the lack of iden-
tified regulators but more recent studies have started to identify
new molecular machineries (Table 1). As for caveolae, no trans-
membrane receptor has yet been found to be a selective cargo
of these dynamin-independent pathways. However, several trans-
membrane receptors are likely to use these pathways in addition
to their clathrin-dependent uptake as first shown for the EGF and
the TGF-β receptors (44, 45). As originally suggested by Schmid et
al. (43), the dynamin-independent pathways are mostly involved
in the uptake of solutes, the so-called fluid-phase uptake, or bulk
flow endocytosis.
THE CLIC/GEEC PATHWAY
This pathway is specifically involved in the uptake of GPI-anchored
proteins (GPI-AP), whose insertion in the external leaflet of
the plasma membrane is mediated by a glycosyl phosphatidyli-
nositol lipidic anchor. GPI-APs are organized as monomers
and/or as nanometer-scale clusters that are associated with lipid
microdomains enriched in cholesterol and sphingolipids (46).
GPI-AP uptake does not depend on clathrin and thereby defines
a novel clathrin-independent endocytic pathway named CLIC for
clathrin-independent carriers. GPI-AP are delivered to a special-
ized endosomal compartment called GEEC for GPI-AP enriched
endocytic compartment that is distinct from the conventional
Rab5 positive early endosome. CLICs display a typical morphol-
ogy with a ring or crescent-like tubular shape. This pathway can
be also distinguished molecularly from the IL2-R pathway since it
does not require the activities of dynamin or RhoA. It is however
regulated by cdc42 and Arf1 (47, 48). The recent identification
of GRAF1 as a BAR domain-containing protein present on the
tubular structures positive for GPI-AP and associated with cdc42
activity allows now to selectively characterize this pathway (49).
The CLIC/GEEC pathway contributes to an important fraction of
the overall fluid-phase uptake of the cell and its efficient recycling
back to the plasma membrane.
FLOTILLINS
Flotillins 1 and 2 present a similar topology with caveolins and
as such are also associated with lipid microdomains. However,
they organize domains that are distinct from caveolar domains.
Flotillin down-expression partially inhibits the uptake of cholera
toxin (CTx) and of GPI-AP in murine fibroblasts (50). The flotillin
endocytic pathway does not require the activity of dynamin, and
appears to rely on the formation of tubular invaginations that are
morphologically close to the caveolar ones. A specific cargo for the
flotillin pathway remains elusive and questions continue particu-
larly on its cellular function. After stimulation by IL6, STAT3 can
be found in DRM fractions also containing flotillin in hepatocar-
cinoma cells (51). Whether the IFNGR and IFNAR subunits can
cofractionate with the STAT molecules in flotillin positive fractions
is still unknown.
Arf6
The expression of a dominant negative mutant of the ADP-
ribosylation factor ARF6 present at the plasma membrane sug-
gested the existence of a novel clathrin-independent pathway
regulated by this small GTPase (52). The GPI-anchored protein
CD59 and MHC class I molecules have been shown to enter the
cell through this pathway (53). Surprisingly, even though CD59 is
GPI-anchored, it does not reach the GEEC endosome described
for the CLIC pathway. Other cargos include carboxypeptidase E,
β1 integrin, and E-cadherin. In fact, it appears that Arf6 rather
regulates the recycling of these cargos to the plasma membrane.
ROLE OF LIPID MICRODOMAINS
OVERVIEW
It is remarkable that all of the clathrin-independent pathways that
have been described so far, including internalization through cave-
olae, have been associated with lipid microdomains of the raft
type. Lipid rafts are membrane microdomains that result from
heterogenous assemblies of certain lipids in the lateral plane of bio-
logical membranes. These domains, which are typically enriched
in glycosphingolipids and cholesterol, show a high degree of lat-
eral diffusion within the plasma membrane allowing thereby the
inclusion or the exclusion of associated proteins or lipids in a
highly dynamic manner. Since the raft concept postulate 15 years
ago (54), many studies have attempted to better analyze the orga-
nization of these microdomains on biological membranes and to
understand their cellular function. The elucidation of the plasma
membrane nanoscale organization has become an intense area
of investigation and to this day remains a work in progress in
the field of cell biology. These studies have been comprehen-
sively reviewed elsewhere (55, 56). Schematically, lipid rafts could
serve as signaling platforms and/or endocytic devices. Most of
the initial studies that have associated lipid rafts with signaling
or endocytosis were based on cholesterol-binding drugs, such as
methyl-β-cyclodextrin, that alter the structural composition of
lipid rafts. Likewise, the association of receptors or signaling mole-
cules with lipid rafts was assumed from their partition into DRMs.
At that time, it was believed that DRMs reflected more or less
faithfully the biochemical composition of lipid rafts in living cells.
Today, the significance of DRM association must be revisited since
more sophisticated techniques have since been available to probe
the nanoscale organization of the plasma membrane with better
temporal and spatial resolution.
LIPID MICRODOMAINS AND SIGNALING
The intrinsic ability of lipid microdomains to assem-
ble/disassemble in a rapid and dynamic manner is quite adapted to
the control of the activation/inactivation cycles of signaling mol-
ecules at the plasma membrane, as evidenced in multiple cases
(57). Two initial studies have reported that IFN-γ led to a rapid
and important redistribution of the activated IFNGR complex
into DRMs at the plasma membrane of different cell types (19,
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58) (Figure 2). The JAK kinases and the STAT molecules have
also been found associated with DRMs in these and other stud-
ies. Accordingly, the cholesterol-binding drug filipin prevented
IFNGR association with DRMs and the initiation of JAK/STAT
signaling by IFN-γ (19). These findings suggest that IFN-γ bind-
ing can actively control the nanoscale organization of IFNGR
complexes and associated molecules of the JAK/STAT signaling
pathway at the plasma membrane. In mouse cells, the IFNAR1
subunit was also detected in detergent-free isolated microdomains
together with JAK and STAT (37). In human cells however, the
IFNAR complex was not DRM associated and IFNAR signal-
ing required IFNAR endocytosis through CCPs (19) (Figure 2).
Whether the preferential association of murine IFNAR with DRMs
is due to the absence of the tyrosine-based motif found in human
IFNAR1 or whether this is caused by variations in DRM isola-
tion protocols is unknown. A recent study confirmed the key role
of IFNGR cholesterol-dependent clustering in IFN-γ biological
activity (59). In the macrophages of Kala-azar patients infected by
the Leishmania donovani, the intracellular life-cycle of the para-
site leads to cholesterol quenching from the plasma membrane.
As a result, IFN-γ failed to induce IFNGR localization into lipid
microdomains, thus allowing the persistence of the parasite in the
macrophage by lack of IFN-γ signaling. This study also identified
the presence of a cholesterol-binding motif [(L/V)-X1–5-Y-X1–5-
(R/K)] within the transmembrane domain (TMD) of the IFNGR1
subunit. Recently, another motif was identified in the TMD of the
human and mouse IFNGR1 subunits that mediates the direct and
specific interaction with sphingolipids only after IFN-γ binding
(60). Whether these motifs are involved in the association of the
IFNGR complex with DRMs and JAK/STAT signaling induced by
IFN-γ is unknown.
This data confirms the importance of lipid-based clustering of
the activated IFNGR in IFN-γ signaling both in vitro and in vivo.
The challenge now is to decipher the molecular interplay occurring
between lipids, the IFNGR, and the JAK/STAT signaling mole-
cules during IFN-γ-induced IFNGR reorganization at the plasma
membrane.
MONITORING RECEPTOR NANOSCALE ORGANIZATION AT THE
PLASMAMEMBRANE
Recent years have seen the emergence of new cell imaging
microscopy techniques which allow the tracking of receptors
FIGURE 2 |The nanoscale organization of the IFNGR complex plays a key
role in JAK/STAT signaling. At steady state, interferon γ receptor subunits 1
and 2 (IFNGR1 and IFNGR2) are partially associated with lipid microdomains
at the plasma membrane. IFN-γ binding results in rapid and dramatic
increased association of the IFNGR heterotetrameric complex with these
domains. IFN-γ-induced clustering is required for the initiation of JAK/STAT
signaling. This is followed by the internalization of IFNGR1 and IFNGR2
through clathrin-coated pits (CCPs) and their delivery to the sorting
endosome. Tetraspanins and galectins are good candidates for modulating
IFNGR clustering and triggering clathrin-independent endocytosis of the IFN-γ
bound receptor complex. Whether clathrin-independent endocytosis is
associated with the control of IFN-γ signaling at the sorting endosome
remains to be tested. In contrast to IFNGR, interferon α receptor subunits 1
and 2 (IFNAR1 and IFNAR2) form a dimeric complex that is rapidly
endocytosed via CCPs after IFN-α binding. JAK/STAT signaling will occur only
after the IFNAR complex has been internalized.
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dynamics at the plasma membrane with improved temporal and
spatial resolution. Single cell imaging techniques such as Förster
resonance energy transfer (FRET), fluorescence lifetime imaging
(FLIM), and fluorescence correlation spectroscopy (FCS) allow
monitoring in a dynamic and quantitative manner of protein
clustering and protein–protein interactions in live cells. Single
molecular tracking of nanometer-sized fluorescent objects such
as Quantum Dots allows recording of the dynamics of clustered
receptors in confined domains over a long time. Finally, super-
resolution fluorescence microscopy has been developed during
the last decade greatly improving the spatial resolution by going
beyond the diffraction limit found by Ernst Abbe in 1873 (61, 62).
These techniques rely on the stochastic illumination of individual
molecules by photoactivated localization microscopy (PALM) or
stochastic optical reconstruction microscopy (STORM). Others
involve a patterned illumination that spatially modulates the flu-
orescence behavior of the molecules within a diffraction-limited
area. This is the case with stimulated emission depletion (STED)
and structured illumination microscopy (SIM). Although these
techniques have increased the resolution down to 20 nm they still
possess intrinsic limitations such at the time of acquisition and
analysis, and the need to overexpress tagged proteins. However,
these limitations are currently addressed at the level of both the
microscope and fluorescent probes (63, 64). The possibility to
simultaneously track the EGF receptor and EGF using two-color
STED imaging is just one recent illustration of these new devel-
opments. Future improvements will certainly allow the imaging
of both the receptor and associated signaling events in a dynamic
manner with nanometer-scale resolution in live cells. While these
techniques have not yet been applied to the IFNGR, they have
been used successfully to study the dynamics of the lateral clus-
tering of multichain immune receptor complexes such as the TCR
and the BCR (65). As shown for IFNGR, ligand binding is the
first step that can result in receptor clustering. Controversy exists
as to whether or not IFNGR1 and IFNGR2 subunits are pre-
assembled before IFN-γ binding (66). Nevertheless, as shown for
the EGF-R, ligand binding can still reorganize and activate already
pre-formed receptor clusters (67). In addition to ligand bind-
ing, several actors including protein–protein and protein–lipid
interactions are likely to contribute to membrane dynamics and
lateral clustering of signaling receptors. Tetraspanins are a fam-
ily of 33 four TMD related hydrophobic proteins that are able
to recognize various molecules including growth factor recep-
tors, integrins and signaling molecules. The so-called tetraspanin
web can organize a highly dynamic supramolecular network of
interacting proteins that controls the lateral diffusion of signaling
clusters at the plasma membrane (68). So far, no study has reported
the interaction of the tetraspanins with IFN receptors. Galectins
are carbohydrate-binding molecules that play pleiotropic cellular
functions. Since the vast majority of signaling receptors are co-
and/or post-translationally conjugated with carbohydrate moi-
eties, galectins represent another example of molecules that could
organize and control receptor clusters at the plasma membrane
through a galectin-glycoprotein or -glycolipid lattice (69). Inter-
estingly, the β-galactoside binding lectin galectin 3 was able to
activate the JAK/STAT signaling pathway in an IFNGR1 dependent
manner in brain-resident immune cells in mice (70). Whether
this was related to the induction of IFNGR clusters has not
been investigated.
The actin cytoskeleton, e.g., actin and actin-binding proteins
can actively induce the formation of receptor clusters and control
their dynamics at the plasma membrane (71). Actin dynamics can
regulate the activity of signaling receptors either by facilitating the
interaction between clusters of receptors and downstream signal-
ing effectors or by preventing this interaction by isolating receptors
from one another. This process was elegantly illustrated by CD36,
a scavenger receptor responsible for the uptake of oxidized LDL
in macrophages. Analysis of CD36 dynamics by single-molecule
tracking showed that actin and microtubules increased the col-
lision frequency between unliganded receptors in membrane
domains thereby controlling CD36 signaling and internalization
(72). Several studies have shown that receptor signaling itself can
remodel the actin cytoskeleton, thus exerting a feedback loop on
receptor diffusion and signaling. A non-exhaustive list of actin-
mediated clustering and signaling examples include the EGF-R,
the T-cell and B-cell receptors, MHC class I molecules, and GPI-
AP such as CD59 (71). The potential role of the actin cytoskeleton
in IFNGR clustering and signaling has not been examined. Yet,
an older story had shown that antibody binding to the IFNGR1
subunit induced capping and actin colocalization (73). Interest-
ingly, the deletion of the LI domain abolished IFNGR1 capping and
redistributed IFNGR1 and actin into micropatches. Whether actin
was required for IFNGR1 endocytosis or signaling has not been
addressed in this study. In general, the role of the actin cytoskele-
ton in mediating the molecular interactions between receptors and
their signaling effectors needs to be better characterized. The actin
cytoskeleton is likely to interact with lipids, the other major actor
in plasma membrane compartmentalization. Indeed, recent stud-
ies show that the actin cytoskeleton can affect lipid microdomain
formation and dynamics, whereas cholesterol can modulate actin
nucleation and dynamics (57).
LIPID MICRODOMAINS AND ENDOCYTOSIS
Besides their role in signaling, recent studies have unveiled a
new function of lipid microdomains in endocytic trafficking. One
puzzling questions that has long remained unresolved in clathrin-
independent endocytosis is to understand how the recruitment of
cargo into endocytic carriers and the tubulation of the plasma
membrane could occur in the absence of the AP-2/clathrin
coat and dynamin, respectively (22). This novel aspect of lipid
microdomain function has been revealed by pioneering studies on
the endocytosis of Shiga toxin (STx), a bacterial toxin produced by
Shigella dysenteriae which enters the cell by clathrin-independent
means after binding to its specific receptor, the glycosphingolipid
Gb3. In order to minimize the energy resulting from local per-
turbations on the plasma membrane, lipid domains will tend to
fuse together, thereby bringing their cargo into larger domains
(74). Thus, Gb3 binding of the B subunit of STx, which has
a characteristic pentameric structure, leads to the compaction
of the outer leaflet of the plasma membrane. It results in local
asymmetries which are translated into an important inward neg-
ative curvature of the plasma membrane inside the cell (75).
The concentration of cargo into those domains can be actively
induced by cortical actin as shown for the GPI-AP monomers and
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clusters (76). Cholesterol plays a stabilizing role for the GPI-AP
homodimers that would otherwise only assemble transiently in
its absence (77). The invagination of lipid microdomains allows
the reduction of the energy at the boundary interface through
the line tension process (78). Line tension is a fundamental
player in the scission of vesicles in the absence of dynamin. In
this case, actin polymerization can reorganize the membrane by
assembling distinct lipid domains whose boundary is energeti-
cally more favorable to membrane scission (79). In addition to
their endocytosis through active reorganization of lipid domains,
CTx and STx B can also enter the cell through caveolae and
CCPs, respectively. Although most IFNGR are internalized by
CCPs (19), it is still possible that according to the cell type or
IFN-γ concentration, IFNGR could be endocytosed through a sim-
ilar process involving the active clustering of IFNGR through the
actin cytoskeleton or by some unidentified selective cross-linker
molecules. As discussed above, tetraspanins or galectins are good
candidates (Figure 2).
ENDOCYTOSIS AND SIGNALING
In the context of intracellular signaling, endocytosis allows the
rapid and efficient decrease in the number of activated receptors
at the plasma membrane. In addition to this classical role, pio-
neering studies on the EGF-R have established almost 20 years ago
that receptor endocytosis could also actively control the signaling
pathways activated by EGF in a more direct manner (80). Fol-
lowing studies have established the key concept of the “signaling
endosome,” which reflects the finding that endosomes are not sim-
ply passive recipients where internalized receptors can accumulate
but instead serve as sorting stations where signaling initiated at the
plasma membrane can be amplified or terminated (81). Numer-
ous studies have since illustrated the importance of membrane
trafficking in the control of intracellular signaling through tem-
poral and spatial compartmentalization of signaling receptors and
downstream effectors (65). This particular aspect of membrane
trafficking has been overlooked for the IFN-Rs and the classical
view of signaling, where effectors interact in a linear manner from
the plasma membrane to the nucleus, has long prevailed. Accord-
ingly, inhibition of clathrin-dependent machinery had no effect on
the initiation of JAK/STAT signaling and the antiviral and antipro-
liferative activities induced by IFN-γ (19). Instead, as discussed
above, JAK/STAT signaling relies on IFN-γ-induced IFNGR clus-
tering at the plasma membrane. Thus, it is likely that STAT1 is first
recruited to IFNGR positive lipid microdomains to be phosphory-
lated at the plasma membrane, then released to the cytoplasm en
route to the nucleus prior to the uptake of the IFNGR complex by
clathrin-dependent endocytosis. This is in contrast to the IFNAR
complex, which also enters the cell by CCPs and shares some of the
JAK/STAT effectors with the IFNGR complex, but is fully depen-
dent on clathrin-dependent endocytosis for signaling. Therefore,
the nanoscale organization of the activated IFN-R at the plasma
membrane allows a clear dichotomy between IFN-α and IFN-γ for
JAK/STAT signaling (Figure 2). In T lymphocytes, the mutation
of the IFNGR2 LI endocytic motif led to cell surface accumulation
and increased STAT1 activation further demonstrating the role of
IFNGR localization at the plasma membrane for the activation of
JAK/STAT signaling (15).
SIGNALING REGULATION THROUGH CAVEOLAE
Early electron microscopy studies have found IFN-γ and the
IFNGR1 subunit to be localized into caveolae in human lymphoma
cells (36). Whether the IFNGR present in caveolae are activated
and internalized remains unknown. As mentioned above, caveolae
are rather inefficient for endocytosis and it is therefore more likely
that caveolae control IFN-γ-induced signaling through IFNGR
confinement at the plasma membrane. Caveola structure could
allow specific interactions with the IFNGR complex and/or associ-
ated signaling molecules. The N-terminal domain of Cav1 presents
a so-called scaffolding domain (CSD), composed of a stretch of
20 amino acids (residues 82–101) that interacts with cholesterol
at the plasma membrane and is required for the oligomerization
of caveolins (26). Based on pioneering studies with eNOS, it has
been hypothesized that the CSD could interact with a correspond-
ing caveolin binding motif (CBM) that has been found in several
signaling molecules. The CSD would exert a negative regulation
on interacting signaling effectors. IFNAR and IFNGR subunits do
not present a classical CBM motif, yet it remains possible that some
signaling downstream effectors are modulated through this inter-
action. Interestingly, it has been suggested that Cav1 could act as a
suppressor of cytokine signaling (SOCS) by inhibiting the kinase
activity of some JAK family members (82). JAK1 and JAK2 are
good candidates since each contains two typical CBM motifs, one
on the kinase domain and another on the pseudokinase domain.
Recently, a re-examination of the structure of these motifs has
questioned their role in signaling (83). The recent possibility to use
cell permeable inhibitory peptides of the CSD motifs should help
to assess the true function of this domain in caveolae-dependent
signaling (84).
PLASTICITY OF THE PLASMAMEMBRANE
The plasma membrane possesses an intrinsic high level of plasticity
and the IFNGR complex has been localized to distinct specialized
areas of the plasma membrane including CCPs, caveolae, and lipid
microdomains. Each of these locations could carry distinct kinet-
ics of receptor uptake, distinct intracellular distributions, and thus
distinct signaling outcomes. With the exception of caveolae, few
studies, if any, have addressed the possible regulation of receptor
signaling by the clathrin-independent pathways. Noteworthy, after
inhibition of clathrin-dependent endocytosis, there still remains
a residual fraction of IFN-R that can enter the cell (19). Whether
this reflects clathrin-independent endocytic possibilities and/or
alternate control of signaling for a minor fraction of receptors
remains to be established. More sensitive techniques will proba-
bly reveal if some of the IFNGR clusters can also be endocytosed
through lipid microdomains in a process similar to the uptake
of Shiga and cholera toxins. It would be also interesting to ana-
lyze whether STAT1-independent signaling may depend on IFNGR
clathrin-dependent endocytosis and the presence of the endocy-
tosed IFNGR in the endosome (Figure 2). Finally, one can imagine
that IFN-R may follow distinct endocytic pathways according to
the cell type. As mentioned above, IFNGR was localized in caveolae
in hepatocytes. This is unlikely to happen in lymphoid cells that
are devoid of caveolae. Future studies are clearly needed to corre-
late endocytic sorting and signaling specificities within different
cellular contexts.
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CONCLUDING REMARKS
Studies in membrane biology over the past decade have started
to reveal the increasing complexity of plasma membrane organi-
zation at the nanoscale level. Endosomes represent an important
extension of the plasma membrane for the control of receptor
signaling. The inherent plasticity of the plasma membrane com-
bined with the intrinsically high dynamics and connectivity of
the endosomal network multiplies the possibilities of control-
ling in both time and space various aspects of receptor behavior
such as clustering, internalization, and intracellular distribution.
Recently, new structural data on IFNAR have shed light on how
two distinct IFNs, IFNα2 and IFNω, can elicit different receptor-
ligand structural interactions that control complex stability and
signal initiation (85). Whether ligand discrimination may lead to
distinct endocytosis and trafficking outcomes and thereby initi-
ate distinct signaling is an exciting possibility that remains to be
tested. Likewise, distinct trafficking pathways may be associated
to the antiviral or antiproliferative activities of IFNs with the cor-
responding activation or inhibition of selective genes. The recent
possibility to use super-resolution microscopy, high throughput
assays, and quantitative proteomics provides investigators with
new means to have a more comprehensive insight into membrane
dynamics and signaling. The future challenge is to integrate our
current understanding of signaling and membrane trafficking with
other cellular functions such as cell development, cell mechan-
ics, cell migration, host-cell pathogens interactions, and other
disciplines such as immunology, biophysics, metabolism, and ulti-
mately pathophysiology. Our knowledge of IFNGR trafficking is
still in its infancy and many questions remain unanswered. It is
clear that more work is required to understand how membrane
and endosome dynamics can control the signaling outputs of the
IFNGR. This is indeed just the beginning of the journey for the
IFNGR complex.
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